Asia Pacific Next Generation Sequencing Market to witness an outstanding growth by 2027
Drug delivery market in North America
is expected to grow from US$ 572,452.95 Mn in the year 2018 and is expected to
reach US$1,074,679.66 Mn by 2027 growing at a CAGR of 7.4% over the forecast
period.
Driving factors such as a rising number of patients suffering from
chronic diseases and increasing adoption of non-invasive drug delivery systems
are likely to grow the drug delivery systems market in the forecast period.
Whereas, the product recalls for these products are likely to impact the growth
of the drug delivery systems market during the forecast period. On the other
hand, the development of novel drug delivery solutions is likely to be a
prevalent trend in the market. With the improvements in medical devices, and
certain transdermal delivery technologies, the non-invasive mode of drug
delivery is now ready to compete with traditional methods of oral and
injectable routes of drug delivery. The Non-Invasive Drug Delivery Systems
encompasses the broad field of non-invasive drug delivery systems which
includes drug delivery via topical, transdermal-active (device- aided enhanced
penetration), transdermal-passive, trans-ocular membrane, trans-mucosal
membrane, as well as delivery via an alveolar membrane from inhaled medication.
Patient compliance has been found to be much higher when administrated by
non-invasive routes due to decreased pain involved in drug delivery and
therefore, these techniques are considered to be a preferred mode of drug
delivery. The manufacturing cost may also be less for non-invasive dosage forms
as compared to injections in many cases. For instance, inhaled insulin appears
to be a non-invasive, well-tolerated, and liked modality of treatment of
diabetes. In 2014, MannKind Corporation developed Afrezza (insulin human)
inhalation powder, which was approved by FDA. Thus, due to advantages offered
by non-invasive drug delivery devices, the drug delivery systems market is expected
to witness growth during the forecast period.
Get Sample PDF Of Asia Pacific Next Generation Sequencing Market @
The North America drug delivery systems market on the basis of
route of administration is segmented in to oral, transmucosal, injectable,
topical, implantable and ocular. In 2018, the oral segment held the largest
market share of 50.2% of the drug delivery systems market, by route of
administration. The oral segment is expected to dominate its market share in
2027 owing to ease of drug administration, a high degree of flexibility on
dosages and cost-effectiveness.
On the basis of application, the North America drug delivery
systems market is segmented into hospitals & clinics, home care settings,
and others. In 2018, the hospitals and clinics held the largest market share of
56.0% of the drug delivery systems market, by the application. This segment is
also expected to dominate the market in 2027, owing to a large number of the
patient population visiting hospitals and clinics. Also hospitals provide
diagnosis and treatment for various medical conditions.
On the basis of the distribution channel, the North America drug delivery systems market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. In 2018, the hospitals pharmacies held the largest market share of 68.7% of the drug delivery systems market, by distribution channel. This segment is also expected to dominate the market in 2027 as hospital pharmacies provide a larger range of medications, including more specialized and investigational medications.
On the basis of the distribution channel, the North America drug delivery systems market is segmented into hospital pharmacies, retail pharmacies and online pharmacies. In 2018, the hospitals pharmacies held the largest market share of 68.7% of the drug delivery systems market, by distribution channel. This segment is also expected to dominate the market in 2027 as hospital pharmacies provide a larger range of medications, including more specialized and investigational medications.
Ask For Discount @
Some of the major primary and secondary sources for drug delivery
systems included in the report are Centers of Disease Control & Prevention,
Food and Drug Administration, World Health Organization and Other
About Us :
Intelligence Market Research & Consulting, LLP (IMRC) is a global
provider of research reports, business intelligence & consulting services.
We know and understand the importance of market research data for your
institution. Therefore, we have teamed up with the leading research institutes
and strategy specialists to bring to you the latest, niche and most relevant
statistical research.
At IMRC, we have one of the most exhaustive, highly reliable
database of market research reports sourced from publishers and authors after a
thorough quality check and screening of the market study and credentials. We
have a team of key market experts who evaluate the market size, growth
prospects, end-use, applications, value & supply chain and top vendors in
the industry to help the clients to take most accurate and logical business
decisions without any vague assumptions.
Contact
Us:
699, Butler St. Suite 1007
Saugatuck, MI - 49453, United States.
Phone : +1 209
691 5657
Comments
Post a Comment